GIGLIOTTI, Casimiro Luca
 Distribuzione geografica
Continente #
EU - Europa 1.151
NA - Nord America 914
AS - Asia 268
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 2.344
Nazione #
US - Stati Uniti d'America 903
IE - Irlanda 356
DE - Germania 231
IT - Italia 210
SE - Svezia 171
UA - Ucraina 85
HK - Hong Kong 82
CN - Cina 63
FI - Finlandia 46
IN - India 45
SG - Singapore 44
IR - Iran 17
CZ - Repubblica Ceca 16
FR - Francia 12
CA - Canada 11
VN - Vietnam 8
GB - Regno Unito 6
BE - Belgio 5
BR - Brasile 5
GR - Grecia 5
TR - Turchia 5
EU - Europa 4
NL - Olanda 3
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AT - Austria 1
BD - Bangladesh 1
CL - Cile 1
EE - Estonia 1
ES - Italia 1
KR - Corea 1
LK - Sri Lanka 1
Totale 2.344
Città #
Dublin 353
Jacksonville 161
Chandler 88
Dearborn 85
Hong Kong 82
Wilmington 55
Grafing 50
Piemonte 42
Ann Arbor 36
Lawrence 36
Princeton 36
Novara 25
San Mateo 24
Singapore 21
Beijing 18
Munich 18
Düsseldorf 17
Bremen 16
Helsinki 16
Turin 16
Brno 15
Milan 14
Monmouth Junction 14
Andover 11
Mülheim 11
Boardman 9
San Giuliano Milanese 9
Zanjan 9
Dong Ket 8
Torino 7
Toronto 7
Cassano Magnago 6
Hefei 6
Nanjing 6
Norwalk 6
Vercelli 6
Belo Horizonte 5
Borgomanero 5
Brussels 5
Jinan 5
Kocaeli 5
Ashburn 4
Kunming 4
Nanchang 4
Ottawa 4
Redwood City 4
Sacramento 4
Udine 4
Amsterdam 3
Ardabil 3
Asti 3
Augusta 3
Fairfield 3
Fuzhou 3
Gunzenhausen 3
Leawood 3
Menlo Park 3
Monza 3
Paris 3
Sandrigo 3
Strasbourg 3
Woodbridge 3
Berlin 2
Buffalo 2
Castelnuovo Bormida 2
Cortona 2
Guangzhou 2
Horia 2
Legnano 2
New York 2
Odalengo Grande 2
Parma 2
Portland 2
Redmond 2
Seregno 2
Shenyang 2
Trieste 2
Zhengzhou 2
Aix-en-Provence 1
Altavilla Monferrato 1
Assisi 1
Biella 1
Borgo Vercelli 1
Cambridge 1
Casale Monferrato 1
Chaoyang 1
Colombo 1
Cupertino 1
Dallas 1
Dhaka 1
Falkenstein 1
Garden City 1
Genoa 1
Göttingen 1
Hebei 1
Henderson 1
Leinì 1
Madrid 1
Mumbai 1
Nuremberg 1
Totale 1.488
Nome #
ICOS-Ligand Triggering Impairs Osteoclast Differentiation and Function In Vitro and In Vivo 96
Differential induction of IL-17, IL-10, and IL-9 in human T helper cells by B7h and B7.1. 87
Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis 78
IL-17 protects T cells from apoptosis and contributes to development of ALPS-like phenotypes 77
Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia 75
A mutation in caspase-9 decreases the expression of BAFFR and ICOS in patients with immunodeficiency and lymphoproliferation 75
B7h Triggering Inhibits the Migration of Tumor Cell Lines 74
Immunotherapy of experimental melanoma with ICOS-Fc loaded in biocompatible and biodegradable nanoparticles 74
Extracellular proteasome-osteopontin circuit regulates cell migration with implications in multiple sclerosis 73
Cholesteryl butyrate solid lipid nanoparticles inhibit the adhesion and migration of colon cancer cells 70
B7H triggering inhibits osteoclast function in vitro and in vivo 70
Enhanced cytotoxic effect of camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in vivo on orthotopic xenograft tumors 70
Glutathione/pH-responsive nanosponges enhance strigolactone delivery to prostate cancer cells 69
Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis 67
Osteopontin binds ICOSL promoting tumor metastasis 66
Thrombin Cleavage of Osteopontin Modulates Its Activities in Human Cells In Vitro and Mouse Experimental Autoimmune Encephalomyelitis In Vivo 64
Development and characterization of solid lipid nanoparticles loaded with a highly active doxorubicin derivative 64
Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH 62
In Vitro and In Vivo Therapeutic Evaluation of Camptothecin-Encapsulated β-Cyclodextrin Nanosponges in Prostate Cancer 62
B7h triggering inhibits umbilical vascular endothelial cell adhesiveness to tumor cell lines and polymorphonuclear cells 58
Attenuation of immune-mediated influenza pneumonia by targeting the inducible co-stimulator (ICOS) molecule on T cells 57
Solid lipid nanoparticles carrying temozolomide for melanoma treatment. Preliminary in vitro and in vivo studies 56
Anti-rasburicase antibodies induce clinical refractoriness by inhibiting the enzyme catalytic activity 55
Triggering of B7h by the ICOS modulates maturation and migration of monocyte-derived dendritic cells. 51
Inducible T-cell co-stimulator (ICOS) and ICOS ligand are novel players in the multiple-myeloma microenvironment 49
Inducible t-cell costimulator ligand plays a dual role in melanoma metastasis upon binding to osteopontin or inducible t-cell costimulator 49
Improvement in the anti-tumor efficacy of doxorubicin nanosponges in in vitro and in mice bearing breast tumor models 48
Genomic and functional evaluation of TNFSF14 in multiple sclerosis susceptibility 45
Platelets: 'multiple choice' effectors in the immune response and their implication in COVID-19 thromboinflammatory process 44
Solid lipid nanoparticles of cholesteryl butyrate inhibit the proliferation of cancer cells in vitro and in vivo models. 43
Vitamin D Supplementation modulates ICOS+ and ICOS- regulatory T cell in siblings of Children with Type 1 Diabetes 41
The Gut-Brain-Immune Axis in Autism Spectrum Disorders: A State-of-Art Report 39
ICOSL Stimulation by ICOS-Fc Accelerates Cutaneous Wound Healing In Vivo 38
Paclitaxel-loaded nanosponges inhibit growth and angiogenesis in melanoma cell models 36
Tuning of the immune response using peptides loaded in biocompatible and biodegradable nanoparticles 34
Specific transcriptional programs differentiate ICOS from CD28 costimulatory signaling in human Naïve CD4+ T cells 30
Nanoemulsions as delivery systems for poly-chemotherapy aiming at melanoma treatment 30
Role of the C-terminal fragment of osteopontin in multiple sclerosis 30
Eltrombopag second-line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off-treatment: results of a phase II, multicentre, prospective study 29
Cutting-Edge Delivery Systems and Adjuvants in Tolerogenic Vaccines: A Review 27
G protein-coupled receptor 21 in macrophages: An in vitro study 23
Differential Modulation of Human M1 and M2 Macrophage Activity by ICOS-Mediated ICOSL Triggering 18
Genes and Microbiota Interaction in Monogenic Autoimmune Disorders 18
ICOS-Fc as innovative immunomodulatory approach to counteract inflammation and organ injury in sepsis 17
Platelets, Protean Cells with All-Around Functions and Multifaceted Pharmacological Applications 16
Sr-Containing Mesoporous Bioactive Glasses Bio-Functionalized with Recombinant ICOS-Fc: An In Vitro Study 13
Use of Poly Lactic-co-glycolic Acid Nano and Micro Particles in the Delivery of Drugs Modulating Different Phases of Inflammation 13
Electrospun Collagen Scaffold Bio-Functionalized with Recombinant ICOS-Fc: An Advanced Approach to Promote Bone Remodelling 12
Parenteral Nanoemulsions Loaded with Combined Immuno- and Chemo-Therapy for Melanoma Treatment 12
Optimization of an Injectable, Resorbable, Bioactive Cement Able to Release the Anti-Osteoclastogenic Biomolecule ICOS-Fc for the Treatment of Osteoporotic Vertebral Compression Fractures 9
Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis 4
Totale 2.417
Categoria #
all - tutte 13.103
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.103


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020353 0 5 25 2 45 60 70 14 29 67 33 3
2020/2021261 27 8 32 7 38 23 31 2 36 14 34 9
2021/2022360 41 5 26 23 18 2 62 17 19 32 32 83
2022/2023825 47 38 59 12 55 69 29 46 391 14 44 21
2023/2024357 32 22 35 12 48 11 87 11 0 5 36 58
2024/202531 28 3 0 0 0 0 0 0 0 0 0 0
Totale 2.417